Search Results - MESUT SEKER

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, con... by Kowalski, Dariusz M, Cho, Byoung Chul, Lubiniecki, Gregory M, Kush, Debra, Lopes, Gilberto, Adamchuk, Grigory, Ahn, Myung-Ju, Altundag, Ozden, Aoe, Keisuke, Ativitavas, Touch, Beato, Carlos, Bergstrom, Per, Betticher, Daniel, Buddu, Sayeuri, Castro, Hugo, Cay Senler, Filiz, Cerny, Carlos Alexandre Sydow, Chan, Gee-Chen, Chang, Jianhua, Cheng, Susanna, Cherciu, Nelly, Cho, Byoung Chul, Cicenas, Saulius, Cohen, Graham, Costa, Marcos Andre, De Angelis, Flavia, de Azevedo, Sergio Jobim, De Marchi, Pedro Rafael Martins, de The Bustamante Valles, Flor, Doganov, Boyan, Dreosti, Lydia, Duarte, Ricardo, Erman, Mustafa, Fein, Luis, Feng, Jifeng, Fenton, David, Fernandes, Gustavo, Ferreira, Carlos, Fujisaka, Yasuhito, Galvez, Christina, Gil, Nuno, Hall, Jacqueline, Hart, Gregory, He, Yong, Ho, Chung Man James, Horiike, Atsushi, Hu, Yi, Ichiki, Masao, Imamura, Fumio, Jassem, Jacek, Jordaan, Christa, Kaen, Diego, Katakami, Nobuyuki, Kato, Terufumi, Kawaguchi, Tomoya, Kim, Joo Hang, Kowalyszyn, Ruben, Ksienski, Doran, Kubota, Kaoru, Kuusk, Gerli, Laczo, Ibolya, Landers, Gregory, Lazarev, Sergey, Li, Wei, Liu, Zhe, Lopes, Valeria, Lu, Shun, Mas, Luis, Milanova, Zhasmina, Nakahara, Yasuharu, Ohman, Ronny, Ong, Choo Khoon, Ostoros, Gyula, Qin, Shukui, Ramlau, Rodryg, Richardet, Eduardo, Roubec, Jaromir, Rusyn, Andrii, Seki, Nobuhiko, Shimada, Andrea Kazumi, Shparyk, Yaroslav, Sinielnikov, Ivan, Soares, Joao Paulo Holanda, Stara, Zinaida, Tanaka, Hiroshi, Tang, Qiyou, Taranov, Pavel, Tejada, Hermes, Torii, Yoshitaro, Trukhyn, Dmytro, Turdean, Maria, Vera, Luis, Vynnychenko, Ihor, Wang, Jie, Wang, Kai, Yumuk, Fulden, Zambrano, Angela, Zemaitis, Marius, Zhao, Jun, Zhou, Jianying

    Get full text
    Article
  14. 14

    Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial by Llovet, Josep M, Kudo, Masatoshi, Meyer, Tim, Qin, Shukui, Ikeda, Masafumi, Ren, Zhenggang, Lim, Ho Yeong, Cheng, Ann-Lii, Galle, Peter R, Wang, Anran, Mody, Kalgi, Dutcus, Corina, Siegel, Abby B, Thompson, Alexander, Andelkovic, Vladimir, Knox, Jennifer, Davies, Janine, Asselah, Jamil, Brahmania, Mayur, Xu, Ruocai, Pan, Hongming, Gu, Kangsheng, Hao, Chunyi, Cao, Peiguo, Xiao, Juxiang, Bai, Yuxian, Chen, Xiaoming, Yan, Dong, Zhao, Hong, Bonilla, Carlos, Zambrano, Angela, Lema, Mauricio, Restrepo Gutierrez, Juan Carlos, Ramos, Victor, LeSourd, Samuel, Edeline, Julien, Bourliere, Marc, Regnault, Helene, Dauvois, Barbara, Schulze, Kornelius, Waidmann, Oliver, Berres, Marie-Luise, Berg, Thomas, Waldschmidt, Dirk T, Bitzer, Michael, Duffy, Austin, Tonini, Giuseppe, Rizzo, Mimma, Biscaldi, Elisa, Ikeda, Masafumi, Kudo, Masatoshi, Numata, Kazushi, Marusawa, Hiroyuki, Kato, Naoya, Morimoto, Manabu, Yamashita, Tatsuya, Koga, Hironori, Masaki, Tsutomu, Tateishi, Ryosuke, Inaba, Yoshitaka, Arakawa, Tomohiro, Suzuki, Yoshiyuki, Hosaka, Tetsuya, Ryoo, Baek-Yeol, Lim, Ho Yeong, Kim, Tae-You, Hernandez Hernandez, Carlos, Motola Kuba, Daniel, Segura Gonzalez, Manuel, Cabrera Luviano, Jesus, Ramirez Godinez, Francisco, Stedman, Catherine, Wyrwicz, Lucjan, Kraj, Leszek, Surma-Wlodarczyk, Renata, Breder, Valeriy, Sekacheva, Marina, Orlova, Rashida, Vasilyev, Alexander, Zukov, Ruslan, Minguez, Beatriz, Matilla Pena, Ana, Fernandez Castroagudin, Javier, Garcia Sanchez, Araceli, Jeng, Long-Bin, Dechaphunkul, Arunee, Seker, Mesut, Bilici, Mehmet, Cil, Timucin, Ulahannan, Susanna, Zakari, Ahmed, Feun, Lynn, Al-Rajabi, Raed, Sung, Max, Kardosh, Adel, Dodlapati, Jyothi, Agrawal, Saurabh, Gopaluni, Srivalli, Loaiza-Bonilla, Arturo, Frenette, Catherine

    Published in The lancet oncology
    Get full text
    Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20